Relmada Therapeutics, Inc. RLMD Federal State And Local Income Tax Expense Benefit Continuing Operations
Federal State And Local Income Tax Expense Benefit Continuing Operations at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations.
The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s federal state and local income tax expense benefit continuing operations.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s federal state and local income tax expense benefit continuing operations?
- Relmada Therapeutics, Inc. (RLMD) reported federal state and local income tax expense benefit continuing operations of $1.11K in Q4 2025.
- What does federal state and local income tax expense benefit continuing operations mean?
- The aggregate income tax expense or benefit recognized across all applicable government jurisdictions for the company's continuing operations. This metric provides a comprehensive view of the total tax burden or relief relative to operating performance.